LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | $10 | $19 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $6 | $9 | $18 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.2% | 20% | 40.6% | 43% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| % Growth | -13.9% | -20% | 15.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |